MFI of CM-H2CFDA
Supplementary Figure S1 : Glibenclamide does not affect reactive oxygen species (ROS) production by PMNs. Purified PMNs from healthy individuals were treated with glibenclamide (GB, 3, 12 and 50 µM) for 1 h. After treatment PMNs were incubated with 1 µg/ml LPS or fixed B. pseudomallei killed by 1% paraformaldehyde (ratio 1:10) for 1 h and then the PMNs were collected for detection of CM-H2CFDA (General oxidative stress indicator) by flow cytometry. Statistical analysis was performed using Two Way ANOVA comparing each bar of GSH treatment group with no GB of each GB treatment group. The results are expressed as mean ± s.d. from 1 of 2 independent experiments. No asterisk, non significant. 
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